Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001654706-15-000003
Filing Date
2015-10-02
Accepted
2015-10-02 13:43:55
Documents
1
Effectiveness Date
2015-10-02
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9909
  Complete submission text file 0001654706-15-000003.txt   10984
Mailing Address 4320 FOREST PARK AVENUE SUITE 303 ST. LOUIS MO 63108
Business Address 4320 FOREST PARK AVENUE SUITE 303 ST. LOUIS MO 63108 314-882-6886
Antegrin Therapeutics, Inc. (Filer) CIK: 0001654706 (see all company filings)

EIN.: 473395909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-248662 | Film No.: 151139558